Evidence map›Paper›PMID 25848696›Full record

ArticleDevelopmental biology2015

ATP4a is required for development and function of the Xenopus mucociliary epidermis - a potential model to study proton pump inhibitor-associated pneumonia.

Peter Walentek, Tina Beyer, Cathrin Hagenlocher, Christina Müller, Kerstin Feistel, Axel Schweickert, Richard M Harland, Martin Blum

Abstract read
In one paragraph

Article in Developmental biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pepsin and Laryngeal and Hypopharyngeal Carcinomas.Clinical and experimental otorhinolaryngology · 2021
    Review
  9. A 'tad' of hope in the fight against airway disease.Biochemical Society transactions · 2020
    Review
  10. Article
  11. Article
  12. Xenbase: Facilitating the Use ofFrontiers in physiology · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Peter WalentekInstitute of Zoology, University of Hohenheim, Garbenstrasse 30, 70593 Stuttgart, Germany; Department of Molecular and Cell Biology, Center for Integrative Genomics, University of California at Berkeley, Berkeley, CA 94720, USA. Electronic address: walentek@berkeley.edu.
Tina BeyerInstitute of Zoology, University of Hohenheim, Garbenstrasse 30, 70593 Stuttgart, Germany.
Cathrin HagenlocherInstitute of Zoology, University of Hohenheim, Garbenstrasse 30, 70593 Stuttgart, Germany.
Christina MüllerInstitute of Zoology, University of Hohenheim, Garbenstrasse 30, 70593 Stuttgart, Germany.
Kerstin FeistelInstitute of Zoology, University of Hohenheim, Garbenstrasse 30, 70593 Stuttgart, Germany.
Axel SchweickertInstitute of Zoology, University of Hohenheim, Garbenstrasse 30, 70593 Stuttgart, Germany.
Richard M HarlandDepartment of Molecular and Cell Biology, Center for Integrative Genomics, University of California at Berkeley, Berkeley, CA 94720, USA.
Martin BlumInstitute of Zoology, University of Hohenheim, Garbenstrasse 30, 70593 Stuttgart, Germany.
University of Hohenheim · DEUniversity of California, Berkeley · US

Funding

Gene Expression in Amphibian DevlopementR01GM042341 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARLAND, RICHARD M · 1988 to 2016
$5.7M
NIGMS NIH HHS GM42341NIGMS NIH HHS R01 GM042341
6 · The paper itself

Abstract

Proton pump inhibitors (PPIs), which target gastric H(+)/K(+)ATPase (ATP4), are among the most commonly prescribed drugs. PPIs are used to treat ulcers and as a preventative measure against gastroesophageal reflux disease in hospitalized patients. PPI treatment correlates with an increased risk for airway infections, i.e. community- and hospital-acquired pneumonia. The cause for this correlation, however, remains elusive. The Xenopus embryonic epidermis is increasingly being used as a model to study airway-like mucociliary epithelia. Here we use this model to address how ATP4 inhibition may affect epithelial function in human airways. We demonstrate that atp4a knockdown interfered with the generation of cilia-driven extracellular fluid flow. ATP4a and canonical Wnt signaling were required in the epidermis for expression of foxj1, a transcriptional regulator of motile ciliogenesis. The ATP4/Wnt module activated foxj1 downstream of ciliated cell fate specification. In multiciliated cells (MCCs) of the epidermis, ATP4a was also necessary for normal myb expression, apical actin formation, basal body docking and alignment of basal bodies. Furthermore, ATP4-dependent Wnt/β-catenin signaling in the epidermis was a prerequisite for foxa1-mediated specification of small secretory cells (SSCs). SSCs release serotonin and other substances into the medium, and thereby regulate ciliary beating in MCCs and protect the epithelium against infection. Pharmacological inhibition of ATP4 in the mature mucociliary epithelium also caused a loss of MCCs and led to impaired mucociliary clearance. These data strongly suggest that PPI-associated pneumonia in human patients might, at least in part, be linked to dysfunction of mucociliary epithelia of the airways.

Indexed as

AnimalsAnimals, Genetically ModifiedCross InfectionDisease Models, AnimalForkhead Transcription FactorsGene Knockdown TechniquesH(+)-K(+)-Exchanging ATPaseHumansMucociliary ClearancePneumoniaProton Pump InhibitorsRespiratory MucosaWnt Signaling PathwayXenopus laevisXenopus ProteinsATP4a protein, XenopusForkhead Transcription FactorsFOXJ1 protein, XenopusH(+)-K(+)-Exchanging ATPaseProton Pump InhibitorsXenopus ProteinsATP4CiliaProton pump inhibitorSmall secretory cellsWntXenopus laevis

Identifiers

PMID25848696
PMCPMC4592800
OpenAlexW2094756380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.